• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Worse Clinical Outcomes, Higher Mortality Rates, and Shorter Lifespans in Epilepsy and Dementia: Ifrah Zawar, MD

Video

The assistant professor of neurology at the University of Virginia spoke at the 2022 American Epilepsy Society Annual Meeting about clinical outcomes of patients with dementia who experience seizures.

This video originally appeared on NeurologyLive. The summary below has been lightly edited.

Recent research has proven a strong association between seizures and dementia, as findings have shown the high impact seizures have on clinical and mortality outcomes. As patients with epilepsy experience symptoms of cognitive decline, patients with dementia are similarly at a high risk of developing seizures. In addition, seizures have been often associated with more severe cognitive impairment among patients with dementia.

Recently, Ifrah Zawar, MD, presented an abstract on the clinical outcomes of patients who experience both seizures and dementia during a poster session at the 2022 American Epilepsy Society Annual Meeting, held December 2-6, in Nashville, Tennessee. In her presentation, she provided an overview of the study, in which results demonstrated that patients with active seizures and dementia at a younger age have worse cognition, poorer function, and higher mortality rates compared with patients who have dementia without seizures.

At the meeting, Zawar, assistant professor of neurology at the University of Virginia, sat down with NeurologyLive® for an interview and offered a summary about the current knowns and unknowns about epilepsy and seizures in those with dementia. She also explained the most important aspect of care and the most recent advances of care for patients in this specific population. Zawar provided detail on the previous research that has revealed the knowledge gaps between epilepsy and dementia.

Reference
Zawar I. Seizures in dementia associated with worse clinical outcomes, higher mortality rates and shorter lifespan. Presented at: AES Annual Meeting; December 2-6, 2022; Nashville, TN, and virtual.

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.